Showing Results for: “Glycemic Index and Diabetes”

Abbott is committing $5 million over three years to the American Diabetes Association (ADA) to help close the health disparities gap for underserved diabetes communities, especially people of color and lower-income Americans Today, Abbott and the American Diabetes Association® (ADA) announced that Abbott has become the first anchor sponsor of the Health Equity Now (HEN) platform to address health disparities for people with diabetes. Abbott’s sponsorship includes a three-year, $5 million commitment to support the ADA's advocacy and community-driven projects aimed at removing barriers to care

Data Shows Potential Breakthrough Treatment Option for Glucose Management in Adolescents with Uncontrolled Diabetes Findings from an international study show a once-weekly injection of dulaglutide was superior in improving glycemic control in youth with type 2 diabetes compared to placebo. The trial was presented at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA) in New Orleans, LA, and simultaneously published in The New England Journal of Medicine . The findings come at a time when cases of type 2 diabetes among youth have more than doubled, since the pandemic

The American Diabetes Association ® (ADA) today released the following statement in reaction to the release of the International Diabetes Federation's (IDF) report showing a dramatic increase in the number of people worldwide who've been diagnosed with diabetes. “This data is devastating. We've been watching the steady increase in diabetes globally, and it should be a call to action for everyone. This is a public health epidemic that's been ignored for far too long. Alarming data such as 73.6 million more adults with diabetes since the onset of the pandemic, we need to take American Diabetes

Today, the American Diabetes Association ® (ADA) sent a letter to congressional leadership urging action on legislation to increase transparency in prescription drug rebates and prevent pharmacy benefit manager (PBM) practices from inflating the cost of prescription drugs. “Drug middlemen function at the center of the pharmaceutical supply chain and have virtually unparalleled power to affect drug costs, acting as intermediaries between insurers, manufacturers, and pharmacies,” according to the letter. Drug manufacturers often pay PBMs rebates on their drugs in exchange for coverage, limiting

A new study released by the American Diabetes Association ® (ADA), illustrates the significant barriers that low-income Americans, people of color, older Americans, and people with diabetes living in states with the highest prevalence of the disease face in accessing continuous glucose monitors (CGM). These barriers are especially high for Americans on Medicaid, who are the least likely to have access to a CGM. CGMs continually monitor blood glucose (blood sugar), giving real-time updates. The devices provide significant, potentially life-changing benefits for diabetes management, and in turn

Ten grants from the American Diabetes Association and the American Heart Association’s joint initiative aiming to decrease heart disease and stroke among people living with Type 2 diabetes. The American Diabetes Association ® and the American Heart Association ® have awarded grants to 10 community organizations to help people living with Type 2 diabetes lower their risk for cardiovascular diseases like heart attack, heart failure and stroke. The community grants are part of the leading health non-profits’ joint Know Diabetes by Heart ™ initiative which seeks to reduce cardiovascular events and

The American Diabetes Association ® applauds the West Virginia governor and legislature for passing HB 4543 Recently, House Bill 4543 (HB 4543) was signed into law by West Virginia Governor Jim Justice. This legislation, which was supported by the American Diabetes Association (ADA), will limit cost sharing to $100 per 30-day supply of insulin for those with state-regulated commercial insurance. The new law also provides coverage for diabetes self-management education (DSME) and provides a new coverage mandate for blood glucose monitors, monitor supplies, insulin, injection aids, syringes

The health and safety of those we serve continues to be the top priority of the American Diabetes Association (ADA). At this time, the World Health Organization (WHO) has made the assessment that COVID-19 can be characterized as a pandemic. We agree with The Centers for Disease Control and Prevention (CDC) that COVID-19 (coronavirus) is a serious public health threat—and older adults and people with serious chronic medical conditions, including diabetes, are at a higher risk of getting very sick from it. The CDC reports that people in places where ongoing community spread of the virus that

The ADA has resources for people with diabetes at diabetes.org/coronoavirus The CDC has determined that COVID-19 is a serious public health threat. In general people with diabetes face greater risks of complications when dealing with viral infections like flu, and that is likely to be true with COVID-19. Recommended safety precautions are the same as for flu, such as frequent hand washing and covering coughs and sneezes with a tissue. The CDC does not recommend the use of face masks by people who are not infected. The American Diabetes Association (ADA) encourages people with diabetes to

In conjunction with a session at the Academy of Nutrition and Dietetics Food & Nutrition Conference & Expo (FNCE), the American Diabetes Association (ADA) is releasing a new resource to help people living with diabetes answer one of the most common and challenging questions: ‘What can I eat?’ The new resource is free and available to download here . “As a dietitian working with patients living with type 2 diabetes, I saw firsthand how critical the food we eat is in managing diabetes,” said Shamera Robinson, MPH, RDN, Associate Director of Nutrition for the ADA. “Unfortunately, there is a lot